Press ROOM

  • Science Series #3: Leukemia

    Leukemia is a cancer of the early blood-forming cells; most often, it is of the white blood cells, but in some cases it starts in other blood cell types. There are several types of leukemia...
  • Interview with doctor Kerdel-Vegas

    Our team had the exceptional opportunity to interview doctor Francisco Kerdel-Vegas, a renowned dermatologist, researcher, diplomat and professor born in Venezuela, currently residing in Spain. Worked with doctor Convit for more than 25 years on infectious diseases.
  • End of year bulletin: Our journey in 2019

    We are pleased to end this new year of efforts and achievements by sharing with you a brief review of our journey during the year.
  • Science Series #2: Molecular Diagnostics​

    In 1990, the Human Genome Project (HGP) began with the primary goal of identifying the 20,000-25,000 genes in human DNA. Although this effort ended in 2003, it is still widely regarded in the scientific community as a monumental feat of coordination and discovery. The resulting information from this 13 year effort has provided a conceptual and technological foundation for a shift in medicine in the near future. Although the project has ended, the challenge of harnessing and applying the information still continues today.
  • New Study on Breast Cancer

    Jacinto Convit World Organization (JCWO) is pleased to announce the publication of their latest work “Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment” in Oncotarget.
  • Science Series #1: Immunotherapy

    Out of the five cancer immunotherapy types listed above, JCWO’s research and development is in the domain of cancer vaccines. This work in immunotherapy began decades ago when Dr. Jacinto Convit successfully developed and applied therapeutic vaccines for Leprosy and Cutaneous Leishmaniasis, the latter being widely used in Venezuela and other Latin-American countries.
  • End of year bulletin: Our journey

    Summary of 2018 achievements for the Jacinto Convit World Organization.
  • Jacinto Convit World Organization publishes a relevant study on a new breast cancer immunotherapy

    Since its inception, the Jacinto Convit World Organization has strived to help the most vulnerable, be useful to others and work for humanity, by continuing to develop a breast cancer immunotherapy (vaccine) designed by Dr. Jacinto Convit during the last years of his life.

Recent News

Terms of Use          Privacy Policy